HEADER TRANSFERASE 28-NOV-20 7B34 TITLE MST3 IN COMPLEX WITH COMPOUND MRIA12 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3,MST-3,STE20-LIKE COMPND 5 KINASE MST3; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE INHIBITORS, STRUCTURE-BASED DRUG DESIGN, SIK2 INHIBITOR, KEYWDS 2 STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.TESCH,M.RAK,A.C.JOERGER,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (SGC) REVDAT 4 31-JAN-24 7B34 1 REMARK REVDAT 3 07-JUL-21 7B34 1 JRNL REVDAT 2 23-JUN-21 7B34 1 JRNL REVDAT 1 16-DEC-20 7B34 0 JRNL AUTH R.TESCH,M.RAK,M.RAAB,L.M.BERGER,T.KRONENBERGER,A.C.JOERGER, JRNL AUTH 2 B.T.BERGER,I.ABDI,T.HANKE,A.POSO,K.STREBHARDT,M.SANHAJI, JRNL AUTH 3 S.KNAPP JRNL TITL STRUCTURE-BASED DESIGN OF SELECTIVE SALT-INDUCIBLE KINASE JRNL TITL 2 INHIBITORS. JRNL REF J.MED.CHEM. V. 64 8142 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34086472 JRNL DOI 10.1021/ACS.JMEDCHEM.0C02144 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0627 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 20782 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2818 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 BIN R VALUE (WORKING SET) : 0.2705 REMARK 3 BIN FREE R VALUE SET COUNT : 170 REMARK 3 BIN FREE R VALUE : 0.3012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2052 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 66 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.260 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL NULL NULL NULL REMARK 3 ORIGIN FOR THE GROUP (A): -41.6647 -9.6601 12.1375 REMARK 3 T TENSOR REMARK 3 T11: 0.3952 T22: 0.5146 REMARK 3 T33: 0.3667 T12: -0.0837 REMARK 3 T13: -0.0451 T23: 0.0003 REMARK 3 L TENSOR REMARK 3 L11: 6.6549 L22: 8.1836 REMARK 3 L33: 6.8478 L12: 1.5974 REMARK 3 L13: -0.5939 L23: -0.8591 REMARK 3 S TENSOR REMARK 3 S11: -0.4303 S12: 0.4851 S13: 0.0846 REMARK 3 S21: -0.7385 S22: 0.6340 S23: 0.3787 REMARK 3 S31: -0.1649 S32: -0.4978 S33: -0.1682 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL NULL NULL NULL REMARK 3 ORIGIN FOR THE GROUP (A): -26.9620 -5.2432 16.6842 REMARK 3 T TENSOR REMARK 3 T11: 0.3374 T22: 0.2685 REMARK 3 T33: 0.2937 T12: -0.0225 REMARK 3 T13: 0.0356 T23: 0.0059 REMARK 3 L TENSOR REMARK 3 L11: 2.8147 L22: 1.8102 REMARK 3 L33: 2.1803 L12: 1.1273 REMARK 3 L13: 1.0937 L23: 1.3290 REMARK 3 S TENSOR REMARK 3 S11: -0.0268 S12: 0.2117 S13: -0.2366 REMARK 3 S21: -0.2313 S22: 0.0678 S23: -0.1293 REMARK 3 S31: 0.0765 S32: -0.0698 S33: -0.0341 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL NULL NULL NULL REMARK 3 ORIGIN FOR THE GROUP (A): -14.5959 6.8539 21.5339 REMARK 3 T TENSOR REMARK 3 T11: 0.2239 T22: 0.2597 REMARK 3 T33: 0.2810 T12: -0.0013 REMARK 3 T13: 0.0189 T23: -0.0125 REMARK 3 L TENSOR REMARK 3 L11: 2.1458 L22: 3.2986 REMARK 3 L33: 2.9742 L12: 0.8623 REMARK 3 L13: 0.2097 L23: -0.4671 REMARK 3 S TENSOR REMARK 3 S11: -0.0699 S12: 0.0959 S13: -0.0349 REMARK 3 S21: -0.1627 S22: 0.0716 S23: -0.2811 REMARK 3 S31: -0.0972 S32: 0.1220 S33: 0.0079 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.11 REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B34 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112392. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00004 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20791 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 39.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3ZHP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 10 MG/ML IN BUFFER REMARK 280 25 MM HEPES PH 7.5, 200 MM NACL, 5% GLYCEROL, 0.5 MM TCEP. REMARK 280 RESERVOIR: 14% PEG 6000, 0.1M HEPES PH 7.2., VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.63100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.53350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.63100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.53350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 ARG A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 7 REMARK 465 TRP A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 ASN A 13 REMARK 465 LYS A 14 REMARK 465 ARG A 15 REMARK 465 ARG A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 HIS A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 GLY A 179 REMARK 465 GLN A 180 REMARK 465 LEU A 181 REMARK 465 THR A 182 REMARK 465 ASP A 183 REMARK 465 THR A 184 REMARK 465 GLN A 185 REMARK 465 ILE A 186 REMARK 465 LYS A 187 REMARK 465 ARG A 188 REMARK 465 ASN A 189 REMARK 465 THR A 190 REMARK 465 PHE A 191 REMARK 465 VAL A 192 REMARK 465 GLY A 193 REMARK 465 SER A 206 REMARK 465 ALA A 207 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 28 CG CD1 CD2 REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 GLU A 73 CG CD OE1 OE2 REMARK 470 ASP A 74 CG OD1 OD2 REMARK 470 GLU A 75 CG CD OE1 OE2 REMARK 470 GLN A 81 CG CD OE1 NE2 REMARK 470 LYS A 103 CG CD CE NZ REMARK 470 ASP A 104 CG OD1 OD2 REMARK 470 LYS A 151 CD CE NZ REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 HIS A 304 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 305 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 39 -148.53 -109.60 REMARK 500 ILE A 42 44.44 -106.65 REMARK 500 GLN A 59 19.18 59.16 REMARK 500 ASP A 104 -120.03 52.26 REMARK 500 ARG A 155 -7.12 88.40 REMARK 500 ASP A 156 53.72 -146.29 REMARK 500 ASP A 209 -159.24 -133.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SQK A 608 DBREF 7B34 A 4 301 UNP Q9Y6E0 STK24_HUMAN 4 301 SEQADV 7B34 MET A 3 UNP Q9Y6E0 INITIATING METHIONINE SEQADV 7B34 ALA A 302 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B34 HIS A 303 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B34 HIS A 304 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B34 HIS A 305 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B34 HIS A 306 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B34 HIS A 307 UNP Q9Y6E0 EXPRESSION TAG SEQADV 7B34 HIS A 308 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 306 MET ARG ALA GLN LEU TRP GLY LEU ALA LEU ASN LYS ARG SEQRES 2 A 306 ARG ALA THR LEU PRO HIS PRO GLY GLY SER THR ASN LEU SEQRES 3 A 306 LYS ALA ASP PRO GLU GLU LEU PHE THR LYS LEU GLU LYS SEQRES 4 A 306 ILE GLY LYS GLY SER PHE GLY GLU VAL PHE LYS GLY ILE SEQRES 5 A 306 ASP ASN ARG THR GLN LYS VAL VAL ALA ILE LYS ILE ILE SEQRES 6 A 306 ASP LEU GLU GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN SEQRES 7 A 306 GLN GLU ILE THR VAL LEU SER GLN CYS ASP SER PRO TYR SEQRES 8 A 306 VAL THR LYS TYR TYR GLY SER TYR LEU LYS ASP THR LYS SEQRES 9 A 306 LEU TRP ILE ILE MET GLU TYR LEU GLY GLY GLY SER ALA SEQRES 10 A 306 LEU ASP LEU LEU GLU PRO GLY PRO LEU ASP GLU THR GLN SEQRES 11 A 306 ILE ALA THR ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP SEQRES 12 A 306 TYR LEU HIS SER GLU LYS LYS ILE HIS ARG ASP ILE LYS SEQRES 13 A 306 ALA ALA ASN VAL LEU LEU SER GLU HIS GLY GLU VAL LYS SEQRES 14 A 306 LEU ALA ASP PHE GLY VAL ALA GLY GLN LEU THR ASP THR SEQRES 15 A 306 GLN ILE LYS ARG ASN THR PHE VAL GLY THR PRO PHE TRP SEQRES 16 A 306 MET ALA PRO GLU VAL ILE LYS GLN SER ALA TYR ASP SER SEQRES 17 A 306 LYS ALA ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU SEQRES 18 A 306 LEU ALA ARG GLY GLU PRO PRO HIS SER GLU LEU HIS PRO SEQRES 19 A 306 MET LYS VAL LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO SEQRES 20 A 306 THR LEU GLU GLY ASN TYR SER LYS PRO LEU LYS GLU PHE SEQRES 21 A 306 VAL GLU ALA CYS LEU ASN LYS GLU PRO SER PHE ARG PRO SEQRES 22 A 306 THR ALA LYS GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG SEQRES 23 A 306 ASN ALA LYS LYS THR SER TYR LEU THR GLU LEU ILE ASP SEQRES 24 A 306 ALA HIS HIS HIS HIS HIS HIS HET EDO A 601 4 HET EDO A 602 4 HET EDO A 603 4 HET EDO A 604 4 HET EDO A 605 4 HET EDO A 606 4 HET EDO A 607 4 HET SQK A 608 36 HETNAM EDO 1,2-ETHANEDIOL HETNAM SQK 8-[(5-AZANYL-1,3-DIOXAN-2-YL)METHYL]-6-[2-CHLORANYL-4- HETNAM 2 SQK (3-FLUORANYL-6-METHYL-PYRIDIN-2-YL)PHENYL]-2- HETNAM 3 SQK (METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-7-ONE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO 7(C2 H6 O2) FORMUL 9 SQK C25 H24 CL F N6 O3 FORMUL 10 HOH *66(H2 O) HELIX 1 AA1 ASP A 31 LEU A 35 1 5 HELIX 2 AA2 GLU A 75 GLN A 88 1 14 HELIX 3 AA3 ALA A 119 LEU A 123 1 5 HELIX 4 AA4 ASP A 129 GLU A 150 1 22 HELIX 5 AA5 LYS A 158 ALA A 160 5 3 HELIX 6 AA6 ALA A 199 GLN A 205 1 7 HELIX 7 AA7 SER A 210 GLY A 227 1 18 HELIX 8 AA8 HIS A 235 ASN A 246 1 12 HELIX 9 AA9 SER A 256 LEU A 267 1 12 HELIX 10 AB1 GLU A 270 ARG A 274 5 5 HELIX 11 AB2 THR A 276 LEU A 281 1 6 HELIX 12 AB3 HIS A 283 ALA A 290 1 8 HELIX 13 AB4 LYS A 292 TYR A 295 5 4 HELIX 14 AB5 LEU A 296 HIS A 306 1 11 SHEET 1 AA1 5 PHE A 36 GLY A 45 0 SHEET 2 AA1 5 GLY A 48 ASP A 55 -1 O LYS A 52 N LEU A 39 SHEET 3 AA1 5 VAL A 61 ASP A 68 -1 O VAL A 62 N GLY A 53 SHEET 4 AA1 5 LYS A 106 GLU A 112 -1 O LEU A 107 N ILE A 67 SHEET 5 AA1 5 TYR A 97 LYS A 103 -1 N TYR A 101 O TRP A 108 SHEET 1 AA2 3 GLY A 117 SER A 118 0 SHEET 2 AA2 3 VAL A 162 LEU A 164 -1 O LEU A 164 N GLY A 117 SHEET 3 AA2 3 VAL A 170 LEU A 172 -1 O LYS A 171 N LEU A 163 SITE 1 AC1 5 HIS A 167 GLY A 253 ASN A 254 TYR A 255 SITE 2 AC1 5 HOH A 755 SITE 1 AC2 5 SER A 272 PHE A 273 ARG A 274 PRO A 275 SITE 2 AC2 5 GLU A 279 SITE 1 AC3 5 LYS A 151 LYS A 152 ILE A 153 ASP A 209 SITE 2 AC3 5 SER A 210 SITE 1 AC4 6 ASP A 156 LYS A 158 ASN A 161 SQK A 608 SITE 2 AC4 6 HOH A 712 HOH A 718 SITE 1 AC5 4 ASP A 209 LYS A 211 PRO A 271 SER A 272 SITE 1 AC6 3 LYS A 278 LEU A 281 LYS A 282 SITE 1 AC7 4 GLU A 166 HIS A 167 ARG A 226 HOH A 724 SITE 1 AC8 19 PHE A 47 VAL A 50 ALA A 63 LYS A 65 SITE 2 AC8 19 ILE A 79 GLU A 82 ILE A 83 LEU A 86 SITE 3 AC8 19 ILE A 109 MET A 111 GLU A 112 LEU A 114 SITE 4 AC8 19 ALA A 160 ASN A 161 LEU A 163 ASP A 174 SITE 5 AC8 19 EDO A 604 HOH A 718 HOH A 721 CRYST1 99.262 59.067 61.795 90.00 93.05 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010074 0.000000 0.000537 0.00000 SCALE2 0.000000 0.016930 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016205 0.00000